Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose cyclopropofol to reduce nausea and vomiting after remimazolam + alfentanil anesthesia
ChiCTR2300070502Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Apr 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Weifang People's Hospital. Primary endpoint: Incidence of nausea and vomiting. Started Apr 2023; status: recruiting.
02
Drugs
ciprofol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2300070502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070502.